CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Commercial Officer James Hassard sold $661K of Crinetics Pharmaceuticals, Inc.
Sold$661,200
$44.08Price
15,000Shares
−34%Stake
What CRNX did after the filing
- The stock from Tue, Jul 9 close, $48.23
- +11.6%
- S&P 500, same days
- +0.5%
Measured over 30 trading days, to the Aug 20 close.
Traded Fri, Jul 5. Filed Tue, Jul 9, 2:04 PM ET, during the session. Returns use the Jul 9 close and the Aug 20 close. Not investment advice.